bluebird bio Announces September Investor Events

On September 5, 2023 bluebird bio, Inc. (Nasdaq: BLUE) reported that members of the management team will participate in fireside chats at the following upcoming investor conferences (Press release, bluebird bio, SEP 5, 2023, View Source [SID1234634881]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Morgan Stanley 21st Annual Global Healthcare Conference, Monday, September 11, at 12:15 p.m. ET at the Sheraton, New York, NY
Baird 2023 Global Healthcare Conference, Tuesday, September 12, at 2:00 p.m. ET at the Intercontinental New York Barclay, New York, NY
To access the live webcast of bluebird bio’s fireside chats, please visit the "Events & Presentations" page within the Investors & Media section of the bluebird bio website at View Source Replays of the webcasts will be available on the bluebird bio website for 90 days following the events.